XL Innovate

XL Innovate operates as an independent partnership, not a corporate venture capital unit. It was funded initially by AXA SA but makes its own investment decisions, carries its own economics, and doesn't take direction from AXA on portfolio construction. This distinguishes it from captive CVC programs that invest off the parent's balance sheet for strategic alignment.

Tom Hutton, the managing partner, leads investment decisions alongside partner Chris Downer. Hutton joined at launch in 2015 with Mike McGavick, who served as CEO while simultaneously leading AXA's XL Catlin division. McGavick later stepped back from day-to-day operations, leaving Hutton and Downer to manage the portfolio.

AXA SA is the sole limited partner and provided all capital for XL Innovate's fund. The firm was created under AXA's ownership following the Paris-based insurer's launch of the XL Catlin brand, with McGavick transitioning from AXA executive to fund CEO. AXA does not control investment decisions despite being the sole LP.

XL Innovate targets seed and Series A rounds, typically writing initial checks of $2 million to $5 million with reserves for follow-on. The fund leads rounds and takes board seats, concentrating on 8-12 companies per fund rather than spraying smaller bets across a broad portfolio of 30-plus startups.

XL Innovate stays within insurance technology and adjacent enterprise platforms. It has not invested in direct-to-consumer insurtech brands that operate as full-stack carriers that compete with incumbents — the portfolio focuses on B2B infrastructure, not distribution disintermediation. The firm does not back health insurance startups or benefits platforms.